Covaxin 50 pc effective against symptomatic COVID: Lancet st

Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of t

Related Keywords

Delhi , India , , World Health Organization , India Institute Of Medical Sciences , Shalini Bhardwajnew Delhi , Lancet Infectious Diseases , All India Institute , Medical Sciences , Professor Naveet Wig , India News , The Study , Ffective , Per Cent , Asymptomatic Covid , World , Covid , Cr Confirmed , Testing Was ,